Takeda and the Boston Medical Center (BMC) have announced a partnership aimed at...
AbbVie has entered a collaboration with Gedeon Richter (Richter) to develop new ...
The committee voted to lower the recommended age for MSD’s Capvaxive and Pfizer’...
At the Outsourcing in Clinical Trials Conference, key opinion leaders shared pre...
New research casts doubt on current advice recommending AF patients wait up to 1...
The Phase III ECZTEND study reported that patients treated with Adbry demonstrat...
A new vaccines drug substance facility and R&D pilot plant, completed by the end...
The California-based Lyell is expected to pay up to $30m in cash along with shar...
The funds will be used to advance Agomab’s candidates through clinical trials, i...
Dyno has formed a new research partnership with Roche on the development of AAV ...
There are already two FDA-approved gene therapies for haemophilia B courtesy of ...
Darzalex will now be available to patients with newly diagnosed multiple myeloma...
Abrysvo is now approved to prevent lower respiratory tract disease caused by RSV...
Ocuphire Pharma has announced the acquisition of Opus Genetics to develop gene t...
The FDA has approved a new presentation of Alvotech and Teva’s SELARSDI, for the...
This NMA serves to bridge the gap between trials for both therapies and compare ...
